Vitamin-D-Metabolismus und Osteoporosebehandlung

Translated title of the contribution: Vitamin D Metabolism and Therapy of Osteoporosis

J. C. Gallagher

Research output: Contribution to journalArticlepeer-review


Pathophysiological changes in vitamin D metabolism lead to hypovitaminosis (osteomalacia) and/or osteoporosis with old age and require a corresponding differential therapy. For patients with hypovitaminosis, i.e. patients with low 25-hydroxyvitamin D3 levels, a treatment with 400-800 I.E. vitamin D per day is the first choice. Subclinical or clinical osteomalacia can also be involved in the development of senile osteoporoses in patients who are more than 80 years of age, particularly in old people's homes. In principle, a distinction between hypovitaminosis and osteoporoses is necessary. There is no evidence that a treatment with low doses of vitamin D contributes significantly to a decrease in the fracture rate of patients suffering from osteoporosis who have normal substrate 25-hydroxyvitamin D levels. However, nearly all large preventive studies on osteoporosis using active vitamin D derivates revealed a significant decrease in the fracture rate while showing a rather low toxicity. The incidence of hypercalcaemia is

Translated title of the contributionVitamin D Metabolism and Therapy of Osteoporosis
Original languageEnglish
Pages (from-to)31-34
Number of pages4
JournalAktuelle Rheumatologie
StatePublished - Oct 1994

All Science Journal Classification (ASJC) codes

  • Rheumatology


Dive into the research topics of 'Vitamin D Metabolism and Therapy of Osteoporosis'. Together they form a unique fingerprint.

Cite this